Journals / The European Research Journal / 2019 / Cilt: 5 - Sayı: 5

The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients

Pages
853–860
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Acomprehensive approach and good patient-physician communication and trust are essential for well-managedhypertension.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) controlamong hypertensive patients that have uncontrolled and controlled BP.Methods: Seventy-eight uncontrolled BP and 98 controlled BP hypertensive patients matched on age, gender,time since hypertension diagnosis and the number of antihypertensive drugs used were investigated using astandardized questionnaire to evaluate lifestyle behaviors, drug adherence, the use of complementary andalternative medicine, and health related quality of life.
📊
Key Findings & Data:Drug-drug interactions were evaluated with an electronicdrug reference software.Results: Not taking therapy when feeling better was observed significantly more frequently in the uncontrolledhypertensive group (OR: 0.297, %95 CI: 0.115-0.770).
💡
Conclusion & Impact:Acomprehensive approach and good patient-physician communication and trust are essential for well-managedhypertension.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) controlamong hypertensive patients that have uncontrolled and controlled BP.Methods: Seventy-eight uncontrolled BP and 98 controlled BP hypertensive patients matched on age, gender,time since hypertension diagnosis and the number of antihypertensive drugs used were investigated using astandardized questionnaire to evaluate lifestyle behaviors, drug adherence, the use of complementary andalternative medicine, and health related quality of life. Drug-drug interactions were evaluated with an electronicdrug reference software.Results: Not taking therapy when feeling better was observed significantly more frequently in the uncontrolledhypertensive group (OR: 0.297, %95 CI: 0.115-0.770). Uncontrolled BP hypertensive patients live morefrequently in extended family settings (p = 0.043), they sleep less controlled BP hypertensive patients (OR:0.749, %95 CI: 0.605-0.929). The groups did not differ statistically in terms of Complementary and AlternativeMedicine (CAM) use (p = 0.795) and informing doctors about the use of CAMs (p = 0.910). The EuroQolfive-dimensional 3 level (EQ5D3L) questionnaire Visual Analogue Scale (VAS) score was significantly higherin the control group (p = 0.011). In both groups over 70% of patients should be monitored for therapy due todrug interactions evaluation.Conclusions: Our study shows that increasing the drug adherence and sleeping hours and living in the nuclearfamily is associated with improvement in blood pressure control and health related quality of life. Acomprehensive approach and good patient-physician communication and trust are essential for well-managedhypertension.

🔖

Cite This Article

Özünal, Z. G., Şen, S., Üresin, A. Y., Tahirbegolli, I. A., Baykal, M., Ateş, B., Tahirbegolli, B., Kılıç, Y. (2022). The drug adherence and lifestyle factors that contribute to blood pressure control among hypertensive patients. The European Research Journal, Cilt: 5 - Sayı: 5, 853–860. https://ajindex.com/articles/597636

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. World Health Organisation-International Society of Hypertension WHO-ISH statement on management of hypertension. J Hypertens 2003;21:1983-92
  2. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries,Canada, and the United States. Hypertension 2004;43:10-17
  3. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22:11-9
  4. Abaci A, Oguz A, Kozan O, Toprak N, Senocak H, Deger N, et al. Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study). J Hum Hyperten 2006;20:355-61
  5. Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension inTurkey (the PatenT study) in 2003. J Hypertens 2005;23:1817-23
  6. Mancia, G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 Practice guidelines for the management of arterialhypertension of the European Society of Hypertension (ESH) and the European Society ofCardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013;31:1925-38
  7. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 2005;12:243-9
  8. Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A. Cultural factors and patients' adherence to lifestyle measures. Br J Gen Pract 2007;57:291-5
  9. Shafiq N, Gupta M, Kumari S, Pandhi P. Prevalence and pattern of use of complementary and alternative medicine (CAM) in hypertensive patients of a tertiary care center in India. Int J Clin Pharmacol Ther 2003;41:294-8
  10. Tan M, Uzun O, Akçay F. Trends in complementary and alternative medicine in Eastern Turkey. J Altern Complement Med 2004;10:861-5
  11. Carter BL, Lund BC, Hayase N, Chrischilles E. The extent of potential antihypertensive drug interactions in aMedicaid population. Am J Hypertens 2002;15:953-7
  12. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Herreros-Fernandez V. Health-related quality of life of subjects with known andunknown hypertension: results from the population-based Hortega study. J Hypertens 2003;21:1283-9
  13. Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related quality of life